Giuseppina Gambino

Naples, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Impact of optimized transcutaneous auricular vagus nerve stimulation on cardiac autonomic profile in healthy subjects and heart failure patients.

Impact of optimized transcutaneous auricular vagus nerve stimulation on cardiac autonomic profile in healthy subjects and heart failure patients.

Journal: Physiological measurement

Published: January 10, 2024

Angiopoietins, vascular endothelial growth factors and secretory phospholipase A2 in heart failure patients with preserved ejection fraction.

Angiopoietins, vascular endothelial growth factors and secretory phospholipase A2 in heart failure patients with preserved ejection fraction.

Journal: European journal of internal medicine

Published: July 28, 2022

Cardiac sympathetic innervation and mortality risk scores in patients with heart failure.

Cardiac sympathetic innervation and mortality risk scores in patients with heart failure.

Journal: European journal of clinical investigation

Published: July 27, 2022

Muscle Ultrasound as Imaging Domain of Frailty.

Muscle Ultrasound as Imaging Domain of Frailty.

Journal: Frontiers in medicine

Published: April 17, 2022

Serum galectin-3 and aldosterone: potential biomarkers of cardiac complications in patients with COVID-19.

Serum galectin-3 and aldosterone: potential biomarkers of cardiac complications in patients with COVID-19.

Journal: Minerva endocrinology

Published: March 10, 2022

Aging is associated with cardiac autonomic nerve fiber depletion and reduced cardiac and circulating BDNF levels.

Aging is associated with cardiac autonomic nerve fiber depletion and reduced cardiac and circulating BDNF levels.

Journal: Journal of geriatric cardiology : JGC

Published: August 18, 2021

Why Do We Not Assess Sympathetic Nervous System Activity in Heart Failure Management: Might GRK2 Serve as a New Biomarker?

Why Do We Not Assess Sympathetic Nervous System Activity in Heart Failure Management: Might GRK2 Serve as a New Biomarker?

Journal: Cells

Published: December 18, 2020

Angiopoietins, Vascular Endothelial Growth Factors and Secretory Phospholipase A2 in Ischemic and Non-Ischemic Heart Failure.

Angiopoietins, Vascular Endothelial Growth Factors and Secretory Phospholipase A2 in Ischemic and Non-Ischemic Heart Failure.

Journal: Journal of clinical medicine

Published: June 01, 2020

Myocardial expression of somatotropic axis, adrenergic signalling, and calcium handling genes in heart failure with preserved ejection fraction and heart failure with reduced ejection fraction.

Myocardial expression of somatotropic axis, adrenergic signalling, and calcium handling genes in heart failure with preserved ejection fraction and heart failure with reduced ejection fraction.

Journal: ESC heart failure

Published: March 13, 2020

Aldosterone Jeopardizes Myocardial Insulin and β-Adrenergic Receptor Signaling via G Protein-Coupled Receptor Kinase 2.

Aldosterone Jeopardizes Myocardial Insulin and β-Adrenergic Receptor Signaling via G Protein-Coupled Receptor Kinase 2.

Journal: Frontiers in pharmacology

Published: January 23, 2019

Aldosterone and Mineralocorticoid Receptor System in Cardiovascular Physiology and Pathophysiology.

Aldosterone and Mineralocorticoid Receptor System in Cardiovascular Physiology and Pathophysiology.

Journal: Oxidative medicine and cellular longevity

Published: July 06, 2018

GRK2 as a therapeutic target for heart failure.

GRK2 as a therapeutic target for heart failure.

Journal: Expert opinion on therapeutic targets

Published: November 24, 2017

Showing 1-12 of 19

Last Updated: 09/26/2026